Benefits of Liquid Biopsy
- Monitoring tumor response to chemotherapy or radiation
- Early detection of recurrence before it appears on scans
- Identifying genetic mutations to guide immunotherapy
Book Liquid Biopsy ctDNA Test | Lahalak Medical Platform
A revolutionary non-invasive blood test providing a safer alternative to traditional biopsies. It detects circulating tumor DNA to monitor cancer progression, recurrence, and guide personalized targeted therapy effectively for patients.
Scientific name: Liquid Biopsy for Circulating Tumor DNA (ctDNA)
An advanced blood test identifying tumor DNA fragments in the bloodstream. It assists oncologists in diagnosing tumors, monitoring treatment response, and detecting early recurrence without the need for invasive surgical procedures.
Service type
Advanced Laboratory Test
Duration
15-20 minutes
Fasting
Fasting is not required
Included Services
- Venous blood sample collection
- Next-Generation Sequencing (NGS)
- Detailed medical report
Medical Service Information
Target Groups
- Cancer patients undergoing active treatment
- Patients where tissue biopsy is clinically difficult
- Suspected cases of disease recurrence post-remission
Frequently Asked Questions
- Does it replace traditional imaging? No, it complements imaging for better accuracy.
- When are results ready? Results usually take 10 to 14 business days.
Conditions & Notices
- Previous medical reports of the tumor are preferred
- Consult your oncologist to determine the optimal timing
Medical services you might also like
